ANDA 215042, held by Novitium Pharma. Phenoxybenzamine Hydrochloride.
As of Nov 16, 2026, ANDA 215042 (Phenoxybenzamine Hydrochloride), held by Novitium Pharma, was first approved by FDA on Jul 19, 2022, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 19, 2022 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenoxybenzamine Hydrochloride10MG ยท capsule;oral | Phenoxybenzamine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters